Alleviation of cardiotoxic effects of anthracycline glycosides

Details Alleviation of cardiotoxic effects of anthracycline glycosides Alleviation of cardiotoxic effects of anthracycline glycosides

A - Human Necessities

61

K

A61K 31/10 (2006.01) A61K 31/71 (1995.01)

Patent

CA 2150710

Anthracycline glycosides such as doxorubicin (adria- mycin) and daunorubicin have valuable anti-tumorous properties but also display cardiotoxic side effects that limit their usefulness. It has now been discovered that the cardiotoxic side effects in a patient can be reduced or alleviated if the patient is also treated with a lipid-lowering drug having antioxidant property, for example probucol.

Affiliated with

Also associated with

Rating

Alleviation of cardiotoxic effects of anthracycline glycosides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alleviation of cardiotoxic effects of anthracycline glycosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alleviation of cardiotoxic effects of anthracycline glycosides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1786691